Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CVE✓SelectedUSD · CVEMRNA vs CVE performance historyLatest closeAs of-3.45%11/13
Stock and ETF performance explorer

MRNA vs CVE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+218.1%
CVE return
+74.2%
Excess return
+143.9%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioCVEExcessAlpha
1D-3.4%+0.7%-4.1%-3.5%
7D-12.1%+5.9%-18.1%-12.9%
30D-1.3%-10.9%+9.6%+0.3%
3M+250.9%-4.5%+255.4%+250.0%
6M+343.0%-1.0%+344.0%+337.0%
YTD+657.4%+74.7%+582.7%+508.4%
1Y+794.9%+65.8%+729.1%+630.0%
3Y+218.1%+73.2%+145.0%+144.1%
All+218.1%+74.2%+143.9%+144.1%

Cumulative growth

Daily Returns

Daily percentage return beside CVE.

Daily Out/Under-Performance

Portfolio return minus CVE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling